New combo therapy aims to boost energy in kidney patients
NCT ID NCT07537816
First seen Apr 30, 2026 · Last updated Jun 16, 2026 · Updated 10 times
Summary
This study tests whether adding the drug vadadustat to standard anemia treatment improves hemoglobin levels, quality of life, and inflammation in 40 adults on peritoneal dialysis. Participants will receive both the add-on drug and standard care alone in two 8-week periods, with a 4-week break in between. The goal is to see if the combination works better than standard care alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.